One-year treatment retention after a nationwide nonmedical switch from originator to biosimilar etanercept in 2061 patients with inflammatory arthritis followed in the DANBIO registry
2018
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI